ArticleStem cell research & therapy2021

Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.

Mahshid Saleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.